MedTrace Logo

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

NCT05970783 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 414

Last updated 2024-10-17

No results posted yet for this study

Summary

The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease

Conditions

  • Chronic Pelvic Pain

Interventions

DRUG

Jincaopian Tablets

Jincaopian Tablets 0.2g tid p.o.

OTHER

Placebo

Placebo 0.2g tid p.o.

Sponsors & Collaborators

  • Beijing Konruns Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xiuxiang Teng · Beijing Hospital of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-08
Primary Completion
2024-03-11
Completion
2025-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970783 on ClinicalTrials.gov